Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ROCKET II: Switching Kivexa to Truvada in HIV with Raised Cholesterol
NCT00772902Phase 4Completed
- Sponsor
- Gilead Sciences
- Start
- Oct 2008
- Primary completion
- Sep 2009
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 4 trial of emtricitabine + tenofovir disoproxil in human immunodeficiency virus type 1 infection (HIV-1), sponsored by Gilead Sciences. Started Oct 2008; status: completed.
02
Drugs
emtricitabine + tenofovir disoproxil
03
Conditions
human immunodeficiency virus type 1 infection (HIV-1)
Beyond the preview
Go deeper on NCT00772902.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00772902.